Cite
HARVARD Citation
Abrams, R. et al. (2020). A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat. CPT: pharmacometrics & systems pharmacology. pp. 374-383. [Online].